CClinicalTrials.gg
Not yet recruitingNCT06797323WaPRUINUpdated Jan 28, 2025

Evaluating the Feasibility of a Web-App for Pelvic Floor Health in Pregnant Women in the Ferrol Health Area: the WaPRUIN Study

An observational study in Pregnancy and Pelvic Floor Disorder, sponsored by Universidad de Oviedo. Not yet recruiting at 1 site in Spain. Open to female participants. Per ClinicalTrials.gov, last updated 2025-01-28.

Sponsored by Universidad de Oviedo · Observational

From the registry’s dates

  • Primary completion was expected by Nov 2025, 11 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
212
Sex
Female
01

Study summary

This study aims to evaluate the feasibility of using a web-based application to improve pelvic floor health in pregnant women within the Ferrol Health Area, Spain. The intervention involves providing educational resources through a user-friendly digital platform, designed to empower women with knowledge about pelvic floor function and techniques for strengthening it during pregnancy.

The study hypothesizes that a web-based educational tool can effectively increase awareness, engagement, and adherence to pelvic floor exercises among pregnant women, thereby contributing to improved maternal health outcomes. Participants will include pregnant women from the Ferrol Health Area, who will voluntarily use the application during their pregnancy.

The study will assess outcomes related to usability, accessibility, and participant satisfaction with the application, as well as any improvements in pelvic floor-related health indicators. By addressing an important gap in maternal health education, this project has the potential to provide an innovative and scalable solution to enhance prenatal care.

02

Conditions studied

  • Pregnancy
  • Pelvic Floor Disorder
03

In context

Pelvic Floor Disorders

197 studies on the registry are indexed under Pelvic Floor Disorders; 45 are open to participants now.

This study's planned enrollment of 212 is above the median of 140 across 58 observational studies indexed under Pelvic Floor Disorders.

Browse Pelvic Floor Disorders studies →

Lead sponsor

Universidad de Oviedo is the lead sponsor of 3 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of pregnant women from the Ferrol Health Area who receive prenatal care in the Gynecology and Obstetrics Department at Hospital Arquitecto Marcide.

Inclusion criteria

  • Pregnant women attending their first prenatal consultation at the Hospital Arquitecto Marcide.
  • Pregnant women who voluntarily consent to participate in the study by signing the informed consent form.

Exclusion criteria

Exclusion Criteria:

  • Pregnant women who do not have proficiency in the Spanish language.
  • Limitations in using the web-app (e.g., physical, cognitive, or technological barriers).
  • Lack of internet access.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
212 participants (estimated)
Patient registry
No

Groups and cohorts

  • Pregnant women

    Behavioral: Web-Based Application for Pelvic Floor Health

Interventions

  • BehavioralWeb-Based Application for Pelvic Floor Health

    A user-friendly web application designed to provide educational resources, exercises, and interactive tools aimed at improving pelvic floor health in pregnant women.

06

What researchers measure

Primary outcomes

  1. Feasibility of the Web-App Usage

    To evaluate the feasibility and usability of the "PelviEduca" web-app, which is designed to improve knowledge about pelvic floor health and related conditions during pregnancy in pregnant women within the Ferrol Health Area.

    Time frame: From enrollment to the end of web application use at 8 weeks

Secondary outcomes

  1. Frequency of Web-App Use

    To analyze the frequency of use of the web-app by the participants during the study.

    Time frame: From enrollment to the end of web application use at 8 weeks

  2. Relationship Between Usability and Participant Characteristics

    To describe the relationship between the feasibility and usability of the web-app and the personal characteristics of the participants.

    Time frame: From enrollment to the end of web application use at 8 weeks

  3. Knowledge Improvement on Pelvic Floor Health

    To evaluate whether the use of the web-app contributes to an increase in knowledge regarding pelvic floor health during pregnancy among participants.

    Time frame: From enrollment to the end of web application use at 8 weeks

  4. Effectiveness in Encouraging Pelvic Floor Exercises

    To determine the effectiveness of the web-app in promoting the practice of pelvic floor exercises among participants.

    Time frame: From enrollment to the end of web application use at 8 weeks

  5. Prevalence of Urinary Incontinence at Inclusion

    To describe the percentage of pregnant women presenting urinary incontinence at the time of enrolment in the study

    Time frame: At baseline (time of enrollment)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided — The decision on whether to share individual participant data (IPD) will be made after the completion of the study and analysis of results. Further updates will be provided when available.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06797323
Lead sponsor
Universidad de Oviedo
Responsible party
Raquel Iglesias Méndez (PhD candidate, Universidad de Oviedo) — Principal investigator
First posted
Jan 28, 2025
Start date
Mar 10, 2025 (estimated)
Primary completion
Nov 2025 (estimated)
Completion
Nov 2025 (estimated)
Last update
Jan 28, 2025

Study contacts

Raquel Iglesias-Méndez
Contact
medicinaraquel@gmail.com
+34 626754452

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion